Deerfield Management as of Dec. 31, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 101 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 6.0 | $145M | 9.0M | 16.18 | |
NxStage Medical | 4.6 | $112M | 4.3M | 26.21 | |
Avexis | 4.4 | $107M | 2.2M | 47.73 | |
Portola Pharmaceuticals | 4.3 | $104M | 4.7M | 22.44 | |
Gw Pharmaceuticals Plc ads | 4.3 | $104M | 928k | 111.75 | |
Mylan Nv | 3.5 | $85M | 2.2M | 38.15 | |
Horizon Pharma Plc convertible security | 3.2 | $79M | 83M | 0.95 | |
Aerie Pharmaceuticals | 2.9 | $70M | 1.8M | 37.85 | |
Array Biopharma Inc note 3.000% 6/0 | 2.6 | $63M | 45M | 1.39 | |
Dbv Technologies S A | 2.5 | $61M | 1.7M | 35.13 | |
Vanda Pharmaceuticals (VNDA) | 2.2 | $55M | 3.4M | 15.95 | |
Nevro (NVRO) | 2.2 | $55M | 751k | 72.66 | |
Xencor (XNCR) | 2.2 | $53M | 2.0M | 26.32 | |
Blueprint Medicines (BPMC) | 2.1 | $52M | 1.8M | 28.05 | |
Endologix Inc note 2.250%12/1 | 1.9 | $46M | 51M | 0.90 | |
Anthem (ELV) | 1.9 | $46M | 318k | 143.77 | |
Lannett Company | 1.8 | $44M | 2.0M | 22.05 | |
Flamel Technologies | 1.7 | $42M | 4.1M | 10.39 | |
Wright Med Group Inc note 2.000% 2/1 | 1.7 | $42M | 40M | 1.04 | |
Humana (HUM) | 1.7 | $40M | 198k | 204.03 | |
Trn 4% 04/01/45 | 1.7 | $40M | 48M | 0.84 | |
Universal American | 1.6 | $38M | 3.8M | 9.95 | |
Endologix, Inc. 3.25% 11/01/2020 | 1.4 | $35M | 41M | 0.87 | |
Centene Corporation (CNC) | 1.4 | $34M | 604k | 56.51 | |
Isis Pharmaceuticals Inc Del note 1.000%11/1 | 1.4 | $34M | 33M | 1.02 | |
Healthways Inc note 1.500% 7/0 | 1.3 | $33M | 25M | 1.30 | |
Aetna | 1.2 | $30M | 242k | 124.01 | |
Nevro Corp note 1.750% 6/0 | 1.2 | $30M | 28M | 1.07 | |
Walgreen Boots Alliance (WBA) | 1.2 | $30M | 356k | 82.76 | |
Molina Healthcare Inc conv | 1.2 | $29M | 25M | 1.14 | |
eHealth (EHTH) | 1.2 | $28M | 2.6M | 10.65 | |
Editas Medicine (EDIT) | 1.1 | $28M | 1.7M | 16.23 | |
Galapagos Nv- (GLPG) | 1.1 | $27M | 423k | 64.19 | |
Globus Med Inc cl a (GMED) | 1.1 | $26M | 1.0M | 24.81 | |
Audentes Therapeutics | 1.1 | $26M | 1.4M | 18.27 | |
Syros Pharmaceuticals | 0.9 | $22M | 1.8M | 12.16 | |
Ascendis Pharma A S (ASND) | 0.9 | $21M | 1.1M | 20.24 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $21M | 3.2M | 6.33 | |
Mallinckrodt Pub | 0.8 | $20M | 407k | 49.82 | |
Epizyme | 0.8 | $19M | 1.6M | 12.10 | |
Fluidigm Corporation convertible cor | 0.8 | $19M | 28M | 0.69 | |
Bluebird Bio (BLUE) | 0.8 | $19M | 302k | 61.70 | |
Myovant Sciences | 0.8 | $19M | 1.5M | 12.44 | |
Clovis Oncology Inc note 2.500% 9/1 | 0.7 | $17M | 17M | 1.03 | |
Recro Pharma | 0.7 | $17M | 2.1M | 8.06 | |
Axogen (AXGN) | 0.7 | $17M | 1.8M | 9.00 | |
Zimmer Holdings (ZBH) | 0.6 | $16M | 150k | 103.20 | |
Tesaro | 0.6 | $15M | 112k | 134.48 | |
Array BioPharma | 0.6 | $15M | 1.7M | 8.79 | |
Selecta Biosciences | 0.6 | $15M | 853k | 17.15 | |
Aac Holdings | 0.6 | $14M | 2.0M | 7.24 | |
Spark Therapeutics | 0.6 | $14M | 283k | 49.90 | |
Foamix Pharmaceuticals | 0.6 | $14M | 1.2M | 11.10 | |
Glaukos (GKOS) | 0.6 | $14M | 393k | 34.30 | |
Kite Pharma | 0.6 | $13M | 298k | 44.84 | |
Wave Life Sciences (WVE) | 0.5 | $12M | 472k | 26.15 | |
Adeptus Health Inc-class A | 0.5 | $12M | 1.6M | 7.64 | |
Cytomx Therapeutics (CTMX) | 0.4 | $10M | 943k | 10.99 | |
Ionis Pharmaceuticals (IONS) | 0.4 | $10M | 214k | 47.83 | |
Aclaris Therapeutics (ACRS) | 0.4 | $10M | 375k | 27.14 | |
Invuity | 0.4 | $9.7M | 1.7M | 5.75 | |
Nivalis Therapeutics | 0.3 | $8.4M | 3.7M | 2.24 | |
Oxford Immunotec Global | 0.3 | $7.9M | 529k | 14.95 | |
Loxo Oncology | 0.3 | $8.1M | 251k | 32.12 | |
Akari Therapeutics | 0.3 | $8.1M | 1.2M | 7.04 | |
Keryx Biopharmaceuticals | 0.3 | $7.6M | 1.3M | 5.86 | |
Aralez Pharmaceuticals | 0.3 | $7.3M | 1.6M | 4.41 | |
Axovant Sciences | 0.3 | $7.1M | 568k | 12.42 | |
Five Prime Therapeutics | 0.3 | $6.9M | 138k | 50.11 | |
EXACT Sciences Corporation (EXAS) | 0.3 | $6.7M | 500k | 13.36 | |
Alimera Sciences | 0.3 | $6.3M | 5.9M | 1.08 | |
Advanced Accelerat spon ads each rep 2 ord | 0.2 | $5.6M | 210k | 26.76 | |
Myokardia | 0.2 | $5.5M | 425k | 12.95 | |
Ardelyx (ARDX) | 0.2 | $5.3M | 374k | 14.20 | |
CAS Medical Systems | 0.2 | $5.2M | 3.2M | 1.61 | |
Ra Pharmaceuticals | 0.2 | $4.9M | 324k | 15.19 | |
Steadymed | 0.2 | $4.6M | 1.8M | 2.60 | |
Essa Pharma | 0.2 | $4.6M | 2.1M | 2.19 | |
Scynexis | 0.1 | $3.3M | 1.0M | 3.19 | |
Nanostring Technologies (NSTGQ) | 0.1 | $3.1M | 139k | 22.30 | |
Kempharm | 0.1 | $3.2M | 1.1M | 2.95 | |
Genocea Biosciences | 0.1 | $2.8M | 687k | 4.12 | |
Voyager Therapeutics (VYGR) | 0.1 | $3.0M | 235k | 12.74 | |
Sangamo Biosciences (SGMO) | 0.1 | $2.6M | 838k | 3.05 | |
pSivida | 0.1 | $2.6M | 1.5M | 1.71 | |
Proteon Therapeutics | 0.1 | $2.5M | 1.3M | 1.90 | |
Catabasis Pharmaceuticals | 0.1 | $2.5M | 683k | 3.61 | |
Global Blood Therapeutics In | 0.1 | $2.5M | 171k | 14.45 | |
Celldex Therapeutics | 0.1 | $2.2M | 633k | 3.54 | |
Agile Therapeutics | 0.1 | $2.3M | 398k | 5.70 | |
Proteostasis Therapeutics In | 0.1 | $2.3M | 186k | 12.26 | |
BioScrip | 0.1 | $2.1M | 2.0M | 1.04 | |
Healthways | 0.1 | $1.7M | 76k | 22.75 | |
Pronai Therapeutics | 0.1 | $1.7M | 1.2M | 1.49 | |
Paratek Pharmaceuticals | 0.1 | $1.5M | 100k | 15.40 | |
Neos Therapeutics | 0.1 | $1.3M | 229k | 5.85 | |
Noveliontherapeuti.. | 0.1 | $1.4M | 171k | 8.42 | |
Ocera Therapeutics | 0.1 | $1.2M | 573k | 2.10 | |
Threshold Pharmaceuticals | 0.0 | $969k | 2.2M | 0.44 | |
Streamline Health Solutions | 0.0 | $829k | 663k | 1.25 | |
Acura Pharmaceuticals (ACUR) | 0.0 | $790k | 1.0M | 0.77 |